Working with clinicians from Massachusetts Eye and Ear and Harvard Medical School, a team of EPFL researchers has developed a conformable electrode implant that will allow people with a dysfunctional inner ear to hear again.

By identifying a protein that helps regulate blood glucose and lipids, researchers at UNIGE hope for the rapid development of treatments more effective than current insulin therapy.